John Kasibante

681 total citations
14 papers, 218 citations indexed

About

John Kasibante is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, John Kasibante has authored 14 papers receiving a total of 218 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 8 papers in Infectious Diseases and 5 papers in Surgery. Recurrent topics in John Kasibante's work include Antifungal resistance and susceptibility (8 papers), Fungal Infections and Studies (8 papers) and Infectious Diseases and Tuberculosis (5 papers). John Kasibante is often cited by papers focused on Antifungal resistance and susceptibility (8 papers), Fungal Infections and Studies (8 papers) and Infectious Diseases and Tuberculosis (5 papers). John Kasibante collaborates with scholars based in Uganda, United States and United Kingdom. John Kasibante's co-authors include David R. Boulware, David B. Meya, Kenneth Ssebambulidde, Fiona V Cresswell, Lillian Tugume, Carson Quinn, Mahsa Abassi, Nathan C. Bahr, Enock Kagimu and Morris K Rutakingirwa and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Microbiology Reviews and Clinical Infectious Diseases.

In The Last Decade

John Kasibante

13 papers receiving 217 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John Kasibante Uganda	8	156	143	81	33	12	14	218
Edward Mpoza Uganda	7	160 1.0×	140 1.0×	80 1.0×	38 1.2×	7 0.6×	12	201
Morris K Rutakingirwa Uganda	9	190 1.2×	150 1.0×	160 2.0×	79 2.4×	9 0.8×	18	269
SRUTI S VELAMAKANNI United States	4	187 1.2×	192 1.3×	13 0.2×	13 0.4×	7 0.6×	10	221
Enock Kagimu Uganda	8	170 1.1×	134 0.9×	139 1.7×	67 2.0×	5 0.4×	19	237
Kiiza Kandole Tadeo Uganda	9	144 0.9×	134 0.9×	31 0.4×	22 0.7×	20 1.7×	11	177
Anna Stadelman United States	7	143 0.9×	114 0.8×	112 1.4×	72 2.2×	6 0.5×	13	215
Neelam Khanna India	7	127 0.8×	128 0.9×	50 0.6×	22 0.7×	11 0.9×	9	169
Arunaloke Chakrabarti India	8	207 1.3×	125 0.9×	26 0.3×	7 0.2×	19 1.6×	21	306
Akiko Okawara Japan	7	62 0.4×	55 0.4×	43 0.5×	11 0.3×	3 0.3×	9	140
Pragya Parmar India	11	57 0.4×	30 0.2×	31 0.4×	10 0.3×	12 1.0×	20	506

Countries citing papers authored by John Kasibante

Since Specialization

Citations

This map shows the geographic impact of John Kasibante's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Kasibante with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Kasibante more than expected).

Fields of papers citing papers by John Kasibante

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Kasibante. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Kasibante. The network helps show where John Kasibante may publish in the future.

Co-authorship network of co-authors of John Kasibante

This figure shows the co-authorship network connecting the top 25 collaborators of John Kasibante. A scholar is included among the top collaborators of John Kasibante based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Kasibante. John Kasibante is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Kasibante, John, Todd T. Brown, Jordan E. Lake, & Mohamed Abdel‐Mohsen. (2025). Estrogen Modulation of B Cell Immunity: Implications for HIV Control and Therapeutic Strategies. Comprehensive physiology. 15(5). e70050–e70050.

Boulware, David R., et al.. (2023). Diagnosis and management of cryptococcal meningitis in HIV-infected adults. Clinical Microbiology Reviews. 36(4). e0015622–e0015622. 11 indexed citations

Tugume, Lillian, Kenneth Ssebambulidde, John Kasibante, et al.. (2023). Cryptococcal meningitis. Nature Reviews Disease Primers. 9(1). 62–62. 51 indexed citations

Kagimu, Enock, Nicole Engen, Kenneth Ssebambulidde, et al.. (2022). Therapeutic Lumbar Punctures in Human Immunodeficiency Virus–Associated Cryptococcal Meningitis: Should Opening Pressure Direct Management?. Open Forum Infectious Diseases. 9(9). ofac416–ofac416. 11 indexed citations

Kagimu, Enock, Julius Kiwanuka, Derrick Bary Abila, et al.. (2022). Evaluation of the initial 12 months of a routine cryptococcal antigen screening program in reduction of HIV-associated cryptococcal meningitis in Uganda. BMC Health Services Research. 22(1). 301–301. 4 indexed citations

Atukunda, Mucunguzi, Morris K Rutakingirwa, Lillian Tugume, et al.. (2022). 869. Oral Encochleated Amphotericin B for Cryptococcal Meningitis: a Phase II Randomized Trial. Open Forum Infectious Diseases. 9(Supplement_2). 4 indexed citations

Nuwagira, Edwin, Kathy Huppler Hullsiek, Morris K Rutakingirwa, et al.. (2022). Diagnostic and Prognostic Value of Cerebrospinal Fluid Lactate and Glucose in HIV-Associated Tuberculosis Meningitis. Microbiology Spectrum. 10(4). e0161822–e0161822. 10 indexed citations

Kagimu, Enock, Emily Martyn, John Kasibante, et al.. (2021). COVID-19 and the HIV care continuum in Uganda: minimising collateral damage. SHILAP Revista de lepidopterología. 3. 28–28. 1 indexed citations

Cresswell, Fiona V, David B. Meya, Enock Kagimu, et al.. (2021). High-Dose Oral and Intravenous Rifampicin for the Treatment of Tuberculous Meningitis in Predominantly Human Immunodeficiency Virus (HIV)-Positive Ugandan Adults: A Phase II Open-Label Randomized Controlled Trial. Clinical Infectious Diseases. 73(5). 876–884. 45 indexed citations

10.

Quinn, Carson, et al.. (2020). Tuberculosis IRIS: Pathogenesis, Presentation, and Management across the Spectrum of Disease. Life. 10(11). 262–262. 43 indexed citations

11.

Kasibante, John, Morris K Rutakingirwa, Enock Kagimu, et al.. (2020). Tuberculosis preventive therapy (TPT) to prevent tuberculosis co-infection among adults with HIV-associated cryptococcal meningitis: A clinician’s perspective. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. 20. 100180–100180. 4 indexed citations

12.

Chesdachai, Supavit, Nicole Engen, Joshua Rhein, et al.. (2020). Baseline Serum C-Reactive Protein Level Predicts Mortality in Cryptococcal Meningitis. Open Forum Infectious Diseases. 7(12). ofaa530–ofaa530. 5 indexed citations

13.

Martyn, Emily, Ananta Bangdiwala, Enock Kagimu, et al.. (2020). Cerebrospinal Fluid Bacillary Load by Xpert MTB/RIF Ultra Polymerase Chain Reaction Cycle Threshold Value Predicts 2-Week Mortality in Human Immunodeficiency Virus–Associated Tuberculous Meningitis. Clinical Infectious Diseases. 73(9). e3505–e3510. 9 indexed citations

14.

Kwizera, Richard, Kiiza Kandole Tadeo, John Kasibante, et al.. (2020). Evaluation of the Dynamiker Cryptococcal Antigen Lateral Flow Assay for the Diagnosis of HIV-Associated Cryptococcosis. Journal of Clinical Microbiology. 59(3). 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact